These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 29982232)

  • 1. International Validation of the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for Secondary Prevention in Post-MI Patients: A Collaborative Analysis of the Chronic Kidney Disease Prognosis Consortium and the Risk Validation Scientific Committee.
    Mok Y; Ballew SH; Bash LD; Bhatt DL; Boden WE; Bonaca MP; Carrero JJ; Coresh J; D'Agostino RB; Elley CR; Fowkes FGR; Jee SH; Kovesdy CP; Mahaffey KW; Nadkarni G; Peterson ED; Sang Y; Matsushita K
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 29982232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Risk Stratification of Patients Undergoing Coronary Angiography According to the Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention.
    Zafrir B; Adawi S; Khalaily M; Jaffe R; Eitan A; Barnett-Griness O; Saliba W
    J Am Heart Assoc; 2019 Jul; 8(14):e012433. PubMed ID: 31271083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the atherothrombotic risk score for secondary prevention in patients with acute myocardial infarction: the J-MINUET study.
    Hashimoto T; Minami Y; Ako J; Nakao K; Ozaki Y; Kimura K; Noguchi T; Suwa S; Fujimoto K; Nakama Y; Morita T; Shimizu W; Saito Y; Hirohata A; Morita Y; Inoue T; Okamura A; Mano T; Hirata K; Tanabe K; Shibata Y; Owa M; Tsujita K; Funayama H; Kokubu N; Kozuma K; Uemura S; Tobaru T; Saku K; Oshima S; Nishimura K; Miyamoto Y; Ogawa H; Ishihara M;
    Heart Vessels; 2021 Oct; 36(10):1506-1513. PubMed ID: 33880614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External validation of the TIMI risk score for secondary cardiovascular events among patients with recent myocardial infarction.
    Williams BA; Chagin KM; Bash LD; Boden WE; Duval S; Fowkes FGR; Mahaffey KW; Patel MD; D'Agostino RB; Peterson ED; Kattan MW; Bhatt DL; Bonaca MP
    Atherosclerosis; 2018 May; 272():80-86. PubMed ID: 29579671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management and outcome across the spectrum of high-risk patients with myocardial infarction according to the thrmobolysis in myocardial infarction (TIMI) risk-score for secondary prevention.
    Grinberg T; Bental T; Hammer Y; Assali A; Vaknin-Assa H; Wiessman M; Perl L; Kornowski R; Eisen A
    Clin Cardiol; 2021 Nov; 44(11):1535-1542. PubMed ID: 34469003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction.
    Furtado RHM; Bonaca MP; Raz I; Zelniker TA; Mosenzon O; Cahn A; Kuder J; Murphy SA; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Ruff CT; Nicolau JC; Gause-Nilsson IAM; Fredriksson M; Langkilde AM; Sabatine MS; Wiviott SD
    Circulation; 2019 May; 139(22):2516-2527. PubMed ID: 30882239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease.
    Bonaca MP; Bhatt DL; Storey RF; Steg PG; Cohen M; Kuder J; Goodrich E; Nicolau JC; Parkhomenko A; López-Sendón J; Dellborg M; Dalby A; Špinar J; Aylward P; Corbalán R; Abola MTB; Jensen EC; Held P; Braunwald E; Sabatine MS
    J Am Coll Cardiol; 2016 Jun; 67(23):2719-2728. PubMed ID: 27046162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventable clinical and psychosocial factors predicted two out of three recurrent cardiovascular events in a coronary population.
    Sverre E; Peersen K; Weedon-Fekjær H; Perk J; Gjertsen E; Husebye E; Gullestad L; Dammen T; Otterstad JE; Munkhaugen J
    BMC Cardiovasc Disord; 2020 Feb; 20(1):61. PubMed ID: 32024471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS-TIMI 54.
    Bhatt DL; Bonaca MP; Bansilal S; Angiolillo DJ; Cohen M; Storey RF; Im K; Murphy SA; Held P; Braunwald E; Sabatine MS; Steg PG
    J Am Coll Cardiol; 2016 Jun; 67(23):2732-2740. PubMed ID: 27046160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-Ever Ischemic Stroke and Incident Major Adverse Cardiovascular Events in 93 627 Older Women and Men.
    Sposato LA; Lam M; Allen B; Shariff SZ; Saposnik G;
    Stroke; 2020 Feb; 51(2):387-394. PubMed ID: 31914883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical prediction rule to estimate the absolute 3-year risk of major cardiovascular events after carotid endarterectomy.
    van Lammeren GW; Catanzariti LM; Peelen LM; de Vries JP; de Kleijn DP; Moll FL; Pasterkamp G; Bots ML
    Stroke; 2012 May; 43(5):1273-8. PubMed ID: 22442175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS-TIMI 54 Trial.
    Gencer B; Li XS; Gurmu Y; Bonaca MP; Morrow DA; Cohen M; Bhatt DL; Steg PG; Storey RF; Johanson P; Wang Z; Hazen SL; Sabatine MS
    J Am Heart Assoc; 2020 May; 9(10):e015331. PubMed ID: 32366163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention of Recurrent Cardiovascular Events in a Real-World Cohort of Post-Acute Myocardial Infarction Patients.
    Huang D; Cheng YY; Wong YA; Yung SA; Tam CF; Chan KK; Lam CS; Yiu KH; Hai JJ; Lau CP; Chan EW; Chiang CE; Wong KL; Cheung T; Cheung BM; Feng YQ; Tan N; Chen JY; Yue WS; Hu HX; Chen L; Tse HF; Chan PH; Siu CW
    Circ J; 2019 Mar; 83(4):809-817. PubMed ID: 30799311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rivaroxaban and Aspirin in Patients With Symptomatic Lower Extremity Peripheral Artery Disease: A Subanalysis of the COMPASS Randomized Clinical Trial.
    Kaplovitch E; Eikelboom JW; Dyal L; Aboyans V; Abola MT; Verhamme P; Avezum A; Fox KAA; Berkowitz SD; Bangdiwala SI; Yusuf S; Anand SS
    JAMA Cardiol; 2021 Jan; 6(1):21-29. PubMed ID: 32997098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incident Type 2 Myocardial Infarction in a Cohort of Patients Undergoing Coronary or Peripheral Arterial Angiography.
    Gaggin HK; Liu Y; Lyass A; van Kimmenade RR; Motiwala SR; Kelly NP; Mallick A; Gandhi PU; Ibrahim NE; Simon ML; Bhardwaj A; Belcher AM; Harisiades JE; Massaro JM; D'Agostino RB; Januzzi JL
    Circulation; 2017 Jan; 135(2):116-127. PubMed ID: 27881568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between preoperative renal dysfunction and cardiovascular events (stroke, myocardial infarction, or heart failure or death) within three months of isolated coronary artery bypass grafting.
    Holzmann MJ; Sartipy U
    Am J Cardiol; 2013 Nov; 112(9):1342-6. PubMed ID: 23870631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective, longitudinal study estimating the association between interdialytic weight gain and cardiovascular events and death in hemodialysis patients.
    Cabrera C; Brunelli SM; Rosenbaum D; Anum E; Ramakrishnan K; Jensen DE; Stålhammar NO; Stefánsson BV
    BMC Nephrol; 2015 Jul; 16():113. PubMed ID: 26197758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from a Swedish nationwide study.
    Sigvant B; Hasvold P; Kragsterman B; Falkenberg M; Johansson S; Thuresson M; Nordanstig J
    J Vasc Surg; 2017 Aug; 66(2):507-514.e1. PubMed ID: 28433332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of liraglutide and risk of major cardiovascular events: a register-based cohort study in Denmark and Sweden.
    Svanström H; Ueda P; Melbye M; Eliasson B; Svensson AM; Franzén S; Gudbjörnsdottir S; Hveem K; Jonasson C; Pasternak B
    Lancet Diabetes Endocrinol; 2019 Feb; 7(2):106-114. PubMed ID: 30527909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction.
    Bohula EA; Bonaca MP; Braunwald E; Aylward PE; Corbalan R; De Ferrari GM; He P; Lewis BS; Merlini PA; Murphy SA; Sabatine MS; Scirica BM; Morrow DA
    Circulation; 2016 Jul; 134(4):304-13. PubMed ID: 27440003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.